Cas:6575-05-9 2,4,6-Trichlorobenzonitrile manufacturer & supplier

We serve Chemical Name:2,4,6-Trichlorobenzonitrile CAS:6575-05-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,4,6-Trichlorobenzonitrile

Chemical Name:2,4,6-Trichlorobenzonitrile
CAS.NO:6575-05-9
Synonyms:Benzonitrile, 2,4,6-trichloro-;2,4,6-trichloro-benzonitrile;MFCD00052711;2,4,6-Trichlorobenzonitrile;2.4.6-Trichlor-benzonitril;2,4,6-trichlorobenzenecarbonitrile
Molecular Formula:C7H2Cl3N
Molecular Weight:206.456
HS Code:2926909090

Physical and Chemical Properties:
Melting point:80-82°C
Boiling point:303.1±37.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.601
PSA:23.79000
Exact Mass:204.925278
LogP:3.36

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3276
Packing Group:III


Contact us for information like Benzonitrile, 2,4,6-trichloro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4,6-trichlorobenzenecarbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzonitrile, 2,4,6-trichloro- Use and application,Benzonitrile, 2,4,6-trichloro- technical grade,usp/ep/jp grade.


Related News: For example, there are concerns that PFAS’ effect on the thyroid could lead to thyroid cancer, van Gerwen said. 2,4,6-Trichlorobenzonitrile manufacturer Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined. 2,4,6-Trichlorobenzonitrile supplier Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. 2,4,6-Trichlorobenzonitrile vendor Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. 2,4,6-Trichlorobenzonitrile factory Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days.